A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal Tumors
Abroad (travel likely)RecruitingPHASE2
Conditions
Esophageal Cancer · Gastric Cancer · Colorectal Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Lin Shen)
Study leads
Lin Shen
Principal Investigator
Peking University Cancer Hospital & Institute